These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15362245)

  • 1. Canadian Outcomes Study in Dementia: study methods and patient characteristics.
    Sambrook R; Herrmann N; Hébert R; McCracken P; Robillard A; Luong D; Yu A
    Can J Psychiatry; 2004 Jul; 49(7):417-27. PubMed ID: 15362245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for Progression of Alzheimer Disease in a Canadian Population: The Canadian Outcomes Study in Dementia (COSID).
    Herrmann N; Harimoto T; Balshaw R; Lanctôt KL;
    Can J Psychiatry; 2015 Apr; 60(4):189-99. PubMed ID: 26174219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of driving cessation in mild-to-moderate dementia.
    Herrmann N; Rapoport MJ; Sambrook R; Hébert R; McCracken P; Robillard A;
    CMAJ; 2006 Sep; 175(6):591-5. PubMed ID: 16966661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Caregiver burden in dementia: evaluation with a Japanese version of the Zarit caregiver burden interview].
    Hirono N; Kobayashi H; Mori E
    No To Shinkei; 1998 Jun; 50(6):561-7. PubMed ID: 9656252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relation between disease severity and cost of caring for patients with Alzheimer disease in Canada.
    Herrmann N; Tam DY; Balshaw R; Sambrook R; Lesnikova N; Lanctôt KL;
    Can J Psychiatry; 2010 Dec; 55(12):768-75. PubMed ID: 21172097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and Resource Use Associated with Alzheimer's Disease in Italy: Results from an Observational Study.
    Bruno G; Mancini M; Bruti G; Dell'Agnello G; Reed C
    J Prev Alzheimers Dis; 2018; 5(1):55-64. PubMed ID: 29405234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the US.
    Saint-Laurent Thibault C; Özer Stillman I; Chen S; Getsios D; Proskorovsky I; Hernandez L; Dixit S
    J Med Econ; 2015; 18(11):930-43. PubMed ID: 26086535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predictors of long-term institutionalization in patients with Alzheimer's disease: role of caregiver burden].
    Hirono N; Tsukamoto N; Inoue M; Moriwaki Y; Mori E
    No To Shinkei; 2002 Sep; 54(9):812-8. PubMed ID: 12428367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient and caregiver outcomes after 6 +/- 1.5-months of rivastigmine therapy for mild-to-moderate Alzheimer's disease: the Belgian FExT study.
    Mets T; Vandewoude M; Jacquy J; Deblander A; MacDonald K; Sloesen A; Abraham I;
    Curr Med Res Opin; 2007 Oct; 23(10):2485-501. PubMed ID: 17784995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study.
    Lenox-Smith A; Reed C; Lebrec J; Belger M; Jones RW
    BMC Geriatr; 2016 Nov; 16(1):195. PubMed ID: 27887645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and predictors of burden in caregivers of people with dementia.
    Brodaty H; Woodward M; Boundy K; Ames D; Balshaw R;
    Am J Geriatr Psychiatry; 2014 Aug; 22(8):756-65. PubMed ID: 24012226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: a randomized controlled trial.
    Callahan CM; Boustani MA; Unverzagt FW; Austrom MG; Damush TM; Perkins AJ; Fultz BA; Hui SL; Counsell SR; Hendrie HC
    JAMA; 2006 May; 295(18):2148-57. PubMed ID: 16684985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-life effectiveness and tolerability of the rivastigmine transdermal patch in patients with mild-to-moderate Alzheimer's disease: the EMBRACE study.
    Gauthier S; Robillard A; Cohen S; Black S; Sampalis J; Colizza D; de Takacsy F; Schecter R;
    Curr Med Res Opin; 2013 Aug; 29(8):989-1000. PubMed ID: 23647369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative importance of patient disease indicators on informal care and caregiver burden in Alzheimer's disease.
    Bergvall N; Brinck P; Eek D; Gustavsson A; Wimo A; Winblad B; Jönsson L
    Int Psychogeriatr; 2011 Feb; 23(1):73-85. PubMed ID: 20619068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings.
    Wimo A; Reed CC; Dodel R; Belger M; Jones RW; Happich M; Argimon JM; Bruno G; Novick D; Vellas B; Haro JM
    J Alzheimers Dis; 2013; 36(2):385-99. PubMed ID: 23629588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
    Lu S; Hill J; Fillit H
    Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of combine treatment of memantine and donepezil on Alzheimer's disease patients and its relationship with cerebral blood flow in the prefrontal area.
    Araki T; Wake R; Miyaoka T; Kawakami K; Nagahama M; Furuya M; Limoa E; Liaury K; Hashioka S; Murotani K; Horiguchi J
    Int J Geriatr Psychiatry; 2014 Sep; 29(9):881-9. PubMed ID: 24436135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Behavioral and psychological symptoms in elderly people with cognitive impairment. Differences between assessment at home and at an adult day-care facility].
    Hashidate H; Harada K; Asakawa Y; Yamagami T; Nihei K; Kaneya S; Yoshii C
    Nihon Koshu Eisei Zasshi; 2012 Aug; 59(8):532-43. PubMed ID: 23066632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between severity of Alzheimer's disease and costs of caring.
    Hux MJ; O'Brien BJ; Iskedjian M; Goeree R; Gagnon M; Gauthier S
    CMAJ; 1998 Sep; 159(5):457-65. PubMed ID: 9757169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.